Your browser doesn't support javascript.
loading
Total marrow lymphoid irradiation IMRT treatment using a novel CT-linac.
Jiang, Dazhen; Deng, Di; Xiong, Yu; Wang, Dajiang; Gong, Jian; Zhao, Hongli; Bao, Zhirong; Wei, Yongchang; Xie, Conghua; Jia, Lecheng; Liao, Can; Liu, Shuo; Liu, Hui; Wang, Xiaoyong.
Affiliation
  • Jiang D; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Deng D; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Xiong Y; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Wang D; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Gong J; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Zhao H; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Bao Z; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Wei Y; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Xie C; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
  • Jia L; United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, 518045, China.
  • Liao C; Shanghai United Imaging Healthcare Co., Ltd, Shanghai, 201807, China.
  • Liu S; Shanghai United Imaging Healthcare Co., Ltd, Shanghai, 201807, China.
  • Liu H; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. hbzkznyy@163.com.
  • Wang X; Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. wangxiaoyong@znhospital.cn.
Eur J Med Res ; 28(1): 463, 2023 Oct 27.
Article in En | MEDLINE | ID: mdl-37884978
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy, Intensity-Modulated Limits: Female / Humans / Male Language: En Journal: Eur J Med Res Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy, Intensity-Modulated Limits: Female / Humans / Male Language: En Journal: Eur J Med Res Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Country of publication: